Sanofi, Disc Will Be First To Test US FDA’s CNPV Pathway

 
• By Michael McCaughan
  
Two CNPV candidates already are under review and should provide the first test of the new FDA pathway. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from United States